The modern epidemiology of heart valve disease
The modern epidemiology of heart valve disease
复制标题
DOI：
10.1136/heartjnl-2014-307020
复制
发表时间：
2016-01-01
期刊：
影响因子：
5.7
通讯作者：
Iung, Bernard
中科院分区：
文献类型：
--
作者：
Coffey, Sean;Cairns, Benjamin J.;Iung, Bernard
在这篇综述中，我们将讨论心脏瓣膜病（HVD）流行病学的现有知识，它如何随着时间的推移和可能的未来趋势而变化。高收入和低收入国家之间以及不同形式的HVD之间的HVD流行病学存在很大差异。在全球范围内，HVD引起的大部分发病率和死亡率是由风湿性心脏病（RHD）引起的，这在低收入国家最常见。在高收入国家，HVD转诊至医院的最大负担是由于钙化性主动脉瓣疾病（CAVD）。尽管与冠心病相比，HVD的患病率较低，但长期随访的要求以及显著的调查和治疗成本意味着HVD对医疗保健系统的影响不成比例地大。HVD与年龄之间的强相关性，加上全球人口的快速老龄化，意味着HVD已被描述为“下一个心脏病”。1
In this review, we will discuss the current knowledge of heart valve disease (HVD) epidemiology, how it has changed over time and possible future trends. There are large differences in HVD epidemiology between high-income and lowincome countries and across different forms of HVD. The majority of morbidity and mortality attributable to HVD worldwide is due to rheumatic heart disease (RHD), which is most commonly seen in low-income countries. In high-income countries, the greatest burden of HVD referred to hospital is due to calcific aortic valve disease (CAVD). Although prevalence of HVD is low compared with coronary heart disease, the requirement for long-term follow-up, and significant investigation and treatment costs, means that the impact of HVD on healthcare systems is disproportionately large. The strong association between HVD and age, combined with the rapid ageing of populations worldwide, means that HVD has been described as the ‘next cardiac epidemic’. 1